DLX6-AS1 is an lncRNA that regulates gene expression and has been implicated in various diseases, including cancer and diabetic nephropathy, where its elevated expression contributes to cellular damage and inflammation by modulating pathways such as glycogen synthase kinase-3 beta (GSK-3β) through microRNAs like miR-346. This evidence concerns the gene DLX6 and diabetic kidney disease.